Plateletworks: A screening assay for clopidogrel therapy monitoring in healthy cats |
| |
Authors: | Avril Hamel-Jolette Marilyn Dunn and Christian Bdard |
| |
Institution: | Avril Hamel-Jolette, Marilyn Dunn, and Christian Bédard |
| |
Abstract: | Plateletworks is a screening assay used in human medicine to monitor platelet-inhibiting drugs. As arterial thromboembolism is a common complication in cats suffering from cardiomyopathy, they are often treated with anti-platelet medication. Clopidogrel (Plavix), an anti-platelet aggregation drug, has recently been evaluated in healthy cats. The purpose of this study was to determine if the Plateletworks method can detect a decrease in platelet aggregation in cats receiving clopidogrel. Nine healthy adult cats were used for this study. Platelet aggregation was measured before and after a 3-day clopidogrel treatment (18.75 mg SID). Platelet aggregation after the clopidogrel treatment was significantly lower (P < 0.01). The Plateletworks method appears to be a promising test to monitor clopidogrel therapy in cats. |
| |
Keywords: | |
|
|